SoVote

Decentralized Democracy

House Hansard - 164

44th Parl. 1st Sess.
March 6, 2023 11:00AM
  • Mar/6/23 3:04:58 p.m.
  • Watch
Mr. Speaker, there are very strict rules in place for obtaining and maintaining a controlled substance licence in Canada. These licences by Health Canada for controlled substances are for scientific and medical purposes only. Companies cannot sell products to the general public. Health Canada has contacted the companies holding a licence to reiterate the very narrow parameters of their licence and asked them to retract any misleading statements. If the strict requirements are not being followed, Health Canada will not hesitate in revoking the licences.
85 words
  • Hear!
  • Rabble!
  • star_border
  • Mar/6/23 3:06:38 p.m.
  • Watch
Mr. Speaker, the member knows full well that Health Canada acted swiftly and has issued regulatory letters to Adastra Labs and Sunshine Earth Labs regarding the misinformation they published. Health Canada spoke to both companies and requested immediate action to retract and clarify their statements. Both Adastra Labs and Sunshine Earth Labs issued a retraction and updated their press release. Health Canada issued a bulletin to all licensed dealers across the country clarifying their responsibilities and authorities under their licences.
80 words
  • Hear!
  • Rabble!
  • star_border